AMRN - add to this list: Vascepa REDUCE-IT outcomes trial High Triglycerides With Mixed Dyslipidemia
data due by or around: 09/30/2017 (any-day) Interim analysis announced September 12, 2016 - trial to proceed. Second interim analysis due 3Q 2017. Final data due mid-2018.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.